Wednesday 12 November 2014

Global Cushing's Syndrome Therapeutics Market 2015-2019

Global Cushing's Syndrome Therapeutics Market 2015-2019 is a new market research publication announced by Reportstack. Cushing's syndrome is a condition caused by the prolonged exposure to very high levels of cortisol. This can occur because of the consumption of glucocorticoid drugs or diseases that result in excess cortisol, ACTH, and CRH secretion. Harvey Cushing described the pathophysiology of this condition in 1932. It is more common in women than in men. Cushing's syndrome is also known as hypercortisolism, hypercorticism, hyperadrenocorticism, or Itsenko-Cushing syndrome. Some of the common symptoms of Cushing's syndrome are increase in weight, facial acne, cognitive disorders, and vulnerability to superficial fungus infections, growth of a mass around the collarbone or back of the neck, commonly known as the "buffalo hump," and puffy face or "moon face". Other symptoms include sweating, polyuria, and hypertension, dilation of the capillaries, thinning of the skin, red striae, osteoporosis, diabetes mellitus, immune suppression, sleep disturbances, muscle weakness, hirsutism, baldness, and hypocalcemia. Cushing's syndrome can broadly be classified into corticotropin-dependent Cushing's syndrome and corticotropin-independent Cushing's syndrome.

The analysts forecast the Global Cushing's Syndrome Therapeutics market to grow at a CAGR of 9.41 percent over the period 2014-2019. This report covers the present scenario and the growth prospects of the Global Cushing's Syndrome Therapeutics market for the period 2014-2019. To calculate the market size, the report considers the revenue generated from the sales of various generic, off-label, and branded therapies used in the treatment of Cushing's syndrome caused in humans.

The report also presents the vendor landscape and a corresponding detailed analysis of the top vendors in the Global Cushing's Syndrome Therapeutics market. In addition, the report discusses the major drivers that influence the growth of the market and also outlines the challenges faced by the vendors and the market at large, as well as the key trends that are emerging in the market.

The report Global Cushing's Syndrome Therapeutics market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global BI and Analytics Platform market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Regions

• Americas

• APAC

• EMEA  

    
Key Vendors

• Corcept Therapeutics

• HRA Pharma

• Novartis

Other Prominent Vendors

 • Aspireo Pharmaceuticals

• Cortendo

• ElexoPharm

• Ipsen

• Isis Pharmaceuticals

• Orphagen Pharmaceuticals

• Samaritan Pharmaceuticals

Market Driver

• Presence of Unmet Need

• For a full, detailed list, view our report

Market Challenge

• Adverse Effects of Drugs

• For a full, detailed list, view our report

Market Trend

• Increase in Awareness

• For a full, detailed list, view our report

Key Questions Answered in this Report

• What will the market size be in 2018 and what will the growth rate be?

• What are the key market trends?

• What is driving this market?

• What are the challenges to market growth?

• Who are the key vendors in this market space?

• What are the market opportunities and threats faced by the key vendors?

• What are the strengths and weaknesses of the key vendors?To view the table of contents and know more details please visit Global Cushing's Syndrome Therapeutics Market 2015-2019

No comments:

Post a Comment